Tavia Acquisition Corp. 8K

Tavia Acquisition Corp. and Vita Inclinata Technologies signed a non-binding LOI for a proposed $450 million de-SPAC transaction to take Vita public on Nasdaq, with exclusivity for 45 days and an expected Q4 2026 closing subject to definitive agreements and customary conditions.

On July 13, 2026, Tavia Acquisition Corp. (Nasdaq: TAVI) and Vita Inclinata Technologies, Inc. announced that they signed a non-binding Letter of Intent for a proposed de-SPAC business combination that would take Vita public on Nasdaq at a contemplated pre-money enterprise value of approximately $450 million, contingent on Vita completing a pending strategic acquisition in the defense and industrials market. The parties agreed to a 45-day exclusivity period to conduct due diligence and negotiate a definitive Business Combination Agreement, are seeking non-binding investment indications from institutional and strategic investors with any firm commitments to be disclosed upon signing a definitive agreement, and currently expect to execute such agreement within thirty days with closing anticipated in the fourth quarter of 2026, subject to customary approvals and conditions and with no assurance that the transaction will be completed. Advisors include Cohen & Company Capital Markets and EarlyBirdCapital for Tavia, Greenberg Traurig LLP for Vita, and Reed Smith LLP for Tavia, and the companies plan to file a registration statement and proxy statement/prospectus with the SEC if a definitive agreement is reached.

Filing Facts

CIK

2020385

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-077643

Alert Tier

8